Literature DB >> 16967051

Collagen impairs glucocorticoid actions in airway smooth muscle through integrin signalling.

J V Bonacci1, M Schuliga, T Harris, A G Stewart.   

Abstract

BACKGROUND AND
PURPOSE: Airway wall remodelling in asthma is characterised by a number of structural changes, including an increase in the volume of airway smooth muscle (ASM), and the abundance of the extracellular matrix (ECM) protein, collagen, is increased. We have investigated the mechanism of collagen-induced glucocorticoid resistance of proliferation, and migration of ASM. EXPERIMENTAL APPROACH: ASM cultured from human airways has been seeded on to either type I monomeric collagen or a laminin pentapeptide, YIGSR. The role of alpha2beta1 integrin in the collagen-induced glucocorticoid resistance was investigated using a function blocking monoclonal antibody. KEY
RESULTS: Culture of ASM on collagen I, but not laminin, led to a greater proliferative response that was insensitive to regulation by dexamethasone (100 nM). The anti-migratory effects of the glucocorticoid, fluticasone propionate (1 nM) were also impaired by contact of ASM with collagen. The impaired anti-mitogenic action of dexamethasone was associated with a failure to reduce the levels of the rate-limiting cell cycle regulatory protein, cyclin D1. When signalling through the alpha2beta1 integrin was reduced, dexamethasone-mediated reductions in proliferation and cyclin D1 levels were restored. CONCLUSIONS AND IMPLICATIONS: In the collagen-rich microenvironment of the inflamed and fibrotic asthmatic airway, integrin/ECM interactions may contribute to glucocorticoid resistance.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16967051      PMCID: PMC1978431          DOI: 10.1038/sj.bjp.0706881

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  34 in total

Review 1.  Airway smooth muscle in health and disease; methods of measurement and relation to function.

Authors:  A James; N Carroll
Journal:  Eur Respir J       Date:  2000-04       Impact factor: 16.671

2.  Regulation of human airway mesenchymal cell proliferation by glucocorticoids and beta2-adrenoceptor agonists.

Authors:  John V Bonacci; Alastair G Stewart
Journal:  Pulm Pharmacol Ther       Date:  2005-04-25       Impact factor: 3.410

3.  Myofibroblast involvement in the allergen-induced late response in mild atopic asthma.

Authors:  M J Gizycki; E Adelroth; A V Rogers; P M O'Byrne; P K Jeffery
Journal:  Am J Respir Cell Mol Biol       Date:  1997-06       Impact factor: 6.914

4.  Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle.

Authors:  D Fernandes; E Guida; V Koutsoubos; T Harris; P Vadiveloo; J W Wilson; A G Stewart
Journal:  Am J Respir Cell Mol Biol       Date:  1999-07       Impact factor: 6.914

Review 5.  Airway fibrosis in asthma: mechanisms, consequences, and potential for therapeutic intervention.

Authors:  A E Redington
Journal:  Monaldi Arch Chest Dis       Date:  2000-08

6.  Stimulus-dependent glucocorticoid-resistance of GM-CSF production in human cultured airway smooth muscle.

Authors:  Thai Tran; Darren J Fernandes; Michael Schuliga; Trudi Harris; Linda Landells; Alastair G Stewart
Journal:  Br J Pharmacol       Date:  2005-05       Impact factor: 8.739

7.  Differential effects of extracellular matrix proteins on human airway smooth muscle cell proliferation and phenotype.

Authors:  S J Hirst; C H Twort; T H Lee
Journal:  Am J Respir Cell Mol Biol       Date:  2000-09       Impact factor: 6.914

8.  The production of extracellular matrix proteins by human passively sensitized airway smooth-muscle cells in culture: the effect of beclomethasone.

Authors:  P R Johnson; J L Black; S Carlin; Q Ge; P A Underwood
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

9.  The integrin-linked kinase regulates the cyclin D1 gene through glycogen synthase kinase 3beta and cAMP-responsive element-binding protein-dependent pathways.

Authors:  M D'Amico; J Hulit; D F Amanatullah; B T Zafonte; C Albanese; B Bouzahzah; M Fu; L H Augenlicht; L A Donehower; K Takemaru; R T Moon; R Davis; M P Lisanti; M Shtutman; J Zhurinsky; A Ben-Ze'ev; A A Troussard; S Dedhar; R G Pestell
Journal:  J Biol Chem       Date:  2000-10-20       Impact factor: 5.157

Review 10.  Factors controlling airway smooth muscle proliferation in asthma.

Authors:  Alastair G Stewart; John V Bonacci; Lilly Quan
Journal:  Curr Allergy Asthma Rep       Date:  2004-03       Impact factor: 4.806

View more
  16 in total

1.  Airway smooth muscle cells are insensitive to the anti-proliferative effects of corticosteroids: The novel role of insulin growth factor binding Protein-1 in asthma.

Authors:  Hong Bui; Yassine Amrani; Brian Deeney; Reynold A Panettieri; Omar Tliba
Journal:  Immunobiology       Date:  2019-05-23       Impact factor: 3.144

Review 2.  Extracellular matrix molecules: potential targets in pharmacotherapy.

Authors:  Hannu Järveläinen; Annele Sainio; Markku Koulu; Thomas N Wight; Risto Penttinen
Journal:  Pharmacol Rev       Date:  2009-06       Impact factor: 25.468

Review 3.  [Endoscopic asthma therapy. Sense and nonsense].

Authors:  F J F Herth
Journal:  Internist (Berl)       Date:  2008-11       Impact factor: 0.743

4.  Regulation of IL-17A and implications for TGF-β1 comodulation of airway smooth muscle remodeling in severe asthma.

Authors:  Jon M Evasovic; Cherie A Singer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-02-27       Impact factor: 5.464

Review 5.  Important lessons learned from studies on the pharmacology of glucocorticoids in human airway smooth muscle cells: Too much of a good thing may be a problem.

Authors:  Yassine Amrani; Reynold A Panettieri; Patricia Ramos-Ramirez; Dedmer Schaafsma; Klaudia Kaczmarek; Omar Tliba
Journal:  Pharmacol Ther       Date:  2020-05-27       Impact factor: 12.310

Review 6.  Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma.

Authors:  S S An; T R Bai; J H T Bates; J L Black; R H Brown; V Brusasco; P Chitano; L Deng; M Dowell; D H Eidelman; B Fabry; N J Fairbank; L E Ford; J J Fredberg; W T Gerthoffer; S H Gilbert; R Gosens; S J Gunst; A J Halayko; R H Ingram; C G Irvin; A L James; L J Janssen; G G King; D A Knight; A M Lauzon; O J Lakser; M S Ludwig; K R Lutchen; G N Maksym; J G Martin; T Mauad; B E McParland; S M Mijailovich; H W Mitchell; R W Mitchell; W Mitzner; T M Murphy; P D Paré; R Pellegrino; M J Sanderson; R R Schellenberg; C Y Seow; P S P Silveira; P G Smith; J Solway; N L Stephens; P J Sterk; A G Stewart; D D Tang; R S Tepper; T Tran; L Wang
Journal:  Eur Respir J       Date:  2007-05       Impact factor: 16.671

Review 7.  MicroRNA-638 inhibits human airway smooth muscle cell proliferation and migration through targeting cyclin D1 and NOR1.

Authors:  Hongyu Wang; Huijuan Yao; Bing Yi; Kyosuke Kazama; Yan Liu; Deepak Deshpande; Jian Zhang; Jianxin Sun
Journal:  J Cell Physiol       Date:  2018-08-04       Impact factor: 6.384

8.  Potentiation of large conductance, Ca2+-activated K+ (BK) channels by alpha5beta1 integrin activation in arteriolar smooth muscle.

Authors:  Xin Wu; Yan Yang; Peichun Gui; Yoshiro Sohma; Gerald A Meininger; George E Davis; Andrew P Braun; Michael J Davis
Journal:  J Physiol       Date:  2008-01-24       Impact factor: 5.182

Review 9.  The Aftermath of Bronchoconstriction.

Authors:  Michael J O'Sullivan; Bo Lan
Journal:  J Eng Sci Med Diagn Ther       Date:  2019-01-22

10.  Integrin and GPCR Crosstalk in the Regulation of ASM Contraction Signaling in Asthma.

Authors:  Chun Ming Teoh; John Kit Chung Tam; Thai Tran
Journal:  J Allergy (Cairo)       Date:  2012-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.